International Journal of Cancer Journal

Overview
Identity
View All

publication venue for

Impact of screening on cervical cancer incidence: A population-based case-control study in the United States.. 147:887-896. 2020
Dietary fat and fiber interact to uniquely modify global histone post-translational epigenetic programming in a rat colon cancer progression model.. 143:1402-1415. 2018
Nanomedicine in management of hepatocellular carcinoma: Challenges and opportunities.. 140:1475-1484. 2017
Oncogenic targets Mmp7, S100a9, Nppb and Aldh1a3 from transcriptome profiling of FAP and Pirc adenomas are downregulated in response to tumor suppression by Clotam.. 140:460-468. 2017
MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.. 135:541-550. 2014
Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice.. 134:2778-2788. 2014
Epigenetic inactivation of endothelin-2 and endothelin-3 in colon cancer.. 132:1004-1012. 2013
Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors.. 132:795-806. 2013
Increased incidence of aflatoxin B1-induced liver tumors in hepatitis virus C transgenic mice.. 130:1347-1356. 2012
Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: leiomyosarcoma, liposarcoma and malignant fibrous histiocytoma.. 129:1963-1969. 2011
NADPH oxidase overexpression in human colon cancers and rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).. 128:2581-2590. 2011
Linoleic acid and butyrate synergize to increase Bcl-2 levels in colonocytes.. 128:63-71. 2011
Secretin inhibits cholangiocarcinoma growth via dysregulation of the cAMP-dependent signaling mechanisms of secretin receptor.. 127:43-54. 2010
E2F4 and ribonucleotide reductase mediate S-phase arrest in colon cancer cells treated with chlorophyllin.. 125:2086-2094. 2009
Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells.. 125:1965-1974. 2009
Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell-induced oxidative stress.. 123:2503-2511. 2008
Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death.. 123:543-551. 2008
Lifetime adult weight gain, central adiposity, and the risk of pre- and postmenopausal breast cancer in the Western New York exposures and breast cancer study.. 119:2931-2937. 2006
PSGR2, a novel G-protein coupled receptor, is overexpressed in human prostate cancer.. 118:1471-1480. 2006
Polycyclic aromatic hydrocarbon-inducible DNA adducts: evidence by 32P-postlabeling and use of knockout mice for Ah receptor-independent mechanisms of metabolic activation in vivo.. 103:5-11. 2003
TNF-alpha has no direct in vivo metabolic effect on human muscle.. 71:148-154. 1997
Prevalence of HPV infection in esophageal squamous cell carcinoma in Chinese patients and its relationship to the p53 gene mutation.. 72:959-964. 1997
Isolation and characterization of variant benzo[a]pyrene-resistant T47D human breast-cancer cells.. 66:117-123. 1996
An in vitro model of ovarian epithelial carcinogenesis: changes in cell-cell communication and adhesion occurring during neoplastic progression.. 54:828-838. 1993
Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF‐κB and induction of apoptosis. 565-576.
SET domain containing 1B gene is mutated in primary hepatic neuroendocrine tumors.. 145:2986-2995.
Isolation and characterization of variant benzo[a]pyrene-resistant T47D human breast-cancer cells 1996